These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12739579)

  • 1. Challenging Food and Drug Administration interpretations of the Federal Food, Drug, and Cosmetic Act.
    Cooper RM
    Food Drug Law J; 2003; 58(1):1-8. PubMed ID: 12739579
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for a substantial evidence amendment to the informal rulemaking provision of the Federal Food, Drug, and Cosmetic Act.
    Bachrach EE
    Food Drug Law J; 2000; 55(3):293-9. PubMed ID: 11824461
    [No Abstract]   [Full Text] [Related]  

  • 3. The authority of a court to order disgorgement for violations of the Current Good Manufacturing Practices requirement of the Federal Food, Drug, and Cosmetic Act.
    King E; Walsh EM
    Food Drug Law J; 2003; 58(2):149-68. PubMed ID: 12866550
    [No Abstract]   [Full Text] [Related]  

  • 4. Statutory interpretation--federal Food, Drug, and Cosmetic Act--Third Circuit holds that the FDA can obtain restitution on behalf of consumers--United States v. Lane Labs-USA Inc., 427 F.3d 219 (3d Cir. 2005).
    Harv Law Rev; 2006 Jun; 119(8):2636-43. PubMed ID: 16830436
    [No Abstract]   [Full Text] [Related]  

  • 5. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2004 update--180-day exclusivity under the Hatch-Waxman amendments to the federal Food, Drug, and Cosmetic Act.
    Lietzan EK
    Food Drug Law J; 2004; 59(4):459-63. PubMed ID: 15875350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Federal Drug and Devices Act and the Drug Safety Amendments of 1976.
    Mandl FL
    Am J Hosp Pharm; 1976 Sep; 33(9):937-40. PubMed ID: 984059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A brief history of 180-day exclusivity under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act.
    Lietzan EK
    Food Drug Law J; 2004; 59(2):287-323. PubMed ID: 15298013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Drug Marketing Act Pedigree Requirements; effective date and compliance policy guide; request for comment. Final rule; announcement of effective date; notice of availability; request for comment.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(114):34249-51. PubMed ID: 16795943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food and Drug Administration--part I: Federal agency close-up.
    Kauffman NM; Malevich S; Smith DJ; Petersen-Kauffman LC
    Am J Med Technol; 1980 Jun; 46(6):428-36. PubMed ID: 7386516
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA milestones.
    FDA Consum; 2006; 40(1):36-8. PubMed ID: 16528826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D
    Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015
    [No Abstract]   [Full Text] [Related]  

  • 13. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL
    Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticipating new consumer protection challenges in the food and drug marketplace.
    Parnes LB
    Food Drug Law J; 2008; 63(2):593-9. PubMed ID: 18561480
    [No Abstract]   [Full Text] [Related]  

  • 15. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 17. The battle over the New Drug Regulation Act.
    Rosenfeld A
    Saturday Rev; 1978 Oct; 5(26):12-4. PubMed ID: 10238417
    [No Abstract]   [Full Text] [Related]  

  • 18. New federal regulations for the use of methadone.
    Pachuta DM
    Md State Med J; 1973 Oct; 22(10):68-70. PubMed ID: 4746378
    [No Abstract]   [Full Text] [Related]  

  • 19. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I. Federal regulations concerning use of asbestos filters in manufacturing parenteral drugs.
    Casola AR
    Bull Parenter Drug Assoc; 1975; 29(5):216-8. PubMed ID: 1182330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.